We previously reported that conjugated linoleic acid (CLA), a naturally occurring fatty acid, inhibits the growth of ERalpha(+) MCF-7 and ERalpha(-) MDA-MB-231 human breast cancer cells by negative modulation of the ERK/MAPK pathway and apoptosis induction. Here we show that in these cell lines CLA also down-regulates the PI3K/Akt cascade. In MCF-7 cells CLA also triggers ERalpha/PP2A complex formation reducing the phosphorylation state and transcriptional activity of Eralpha whereas in MDA-MB-231 cells CLA does not induce PP2A activation. Moreover, CLA induces the expression of proteins involved in cell adhesion and inhibits cell migration and MMP-2 activity. These findings suggest that CLA may induce the down-regulation of ERalpha signalling and the reduction of cell invasion through the modulation of balancing between phosphatases and kinases
CLA reduces breast cancer cell growth and invasion through ERα and PI3K/Akt pathways
BOCCA, Claudia;BOZZO, FRANCESCA;CANNITO, STEFANIA;COLOMBATTO, Sebastiano;MIGLIETTA, Antonella
2010-01-01
Abstract
We previously reported that conjugated linoleic acid (CLA), a naturally occurring fatty acid, inhibits the growth of ERalpha(+) MCF-7 and ERalpha(-) MDA-MB-231 human breast cancer cells by negative modulation of the ERK/MAPK pathway and apoptosis induction. Here we show that in these cell lines CLA also down-regulates the PI3K/Akt cascade. In MCF-7 cells CLA also triggers ERalpha/PP2A complex formation reducing the phosphorylation state and transcriptional activity of Eralpha whereas in MDA-MB-231 cells CLA does not induce PP2A activation. Moreover, CLA induces the expression of proteins involved in cell adhesion and inhibits cell migration and MMP-2 activity. These findings suggest that CLA may induce the down-regulation of ERalpha signalling and the reduction of cell invasion through the modulation of balancing between phosphatases and kinasesFile | Dimensione | Formato | |
---|---|---|---|
CHEM-BIOL INTERACT 2010.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
543.32 kB
Formato
Adobe PDF
|
543.32 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
CLA reduces breast.pdf
Open Access dal 01/02/2011
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
511.26 kB
Formato
Adobe PDF
|
511.26 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.